Abstract:Background Specific plaque phenotypes that predict a favorable response to statin therapy have not been systematically studied. This study aimed to identify optical coherence tomography predictors for a favorable vascular response to statin therapy. Methods and Results Patients who had serial optical coherence tomography imaging at baseline and at 6 months were included. Thin‐cap area (defined as an area with fibrous cap thickness <200 μm) was measured using a 3‐dimensional computer‐aided algorithm, and changes in the thin‐cap area at 6 months were calculated. A favorable vascular response was defined as the highest tertile in the degree of reduction of the thin‐cap area. Macrophage index was defined as the product of the average macrophage arc and length of the lesion with macrophage infiltration. Layered plaque was defined as a plaque with 1 or more layers of different optical density. In 84 patients, 140 nonculprit lipid plaques were identified. In multivariable analysis, baseline thin‐cap area (odds ratio [OR] 1.442; 95% CI, 1.024–2.031, P =0.036), macrophage index (OR, 1.031; 95% CI, 1.002–1.061, P =0.036), and layered plaque (OR, 2.767; 95% CI, 1.024–7.479, P =0.045) were identified as the significant predictors for a favorable vascular response. Favorable vascular response was associated with a decrease in the macrophage index. Conclusions Three optical coherence tomography predictors for a favorable vascular response to statin therapy have been identified: large thin‐cap area, high macrophage index, and layered plaque. Favorable vascular response to statin was correlated with signs of decreased inflammation. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538. Nonstandard Abbreviations and Acronyms FC fibrous cap FCT fibrous cap thickness TCFA thin‐cap fibroatheroma Clinical Perspective What Is New? Plaques with features of vulnerability (large thin‐cap area, high macrophage index, and layered plaque) respond more favorably to statin therapy. Significant correlations are observed between the change in the macrophage index and the change in thin‐cap area. The prevalence of layered (vulnerable) plaques significantly increases only in plaques with increased macrophage index. What Are the Clinical Implications? Statin therapy should be started immediately in patients who have optical coherence tomography predictors for a favorable response (large thin‐cap area, high macrophage index, and layered plaque). For patients who have evidence of persistent active inflammation, additional therapies such as anti‐inflammatory agents may need to be considered. Acute coronary syndrome (ACS) is the leading cause of morbidity and mortality in the world. 1 The most common mechanism of ACS is rupture of a lipid plaque. 2 Optical coherence tomography (OCT) studies have revealed that fibrous cap thickness (FCT) is one of the most important determinants of plaque vulnerability. 3 , 4 A previous study reported that 95% of ruptured plaques in patients had FCT <188 μm. 5 Recent studies have demonstrated that statin therapy stabilizes high‐risk plaques by increasing FCT and reducing thin‐cap area. 6 , 7 Recent studies have also shown that layered plaque is a signature of previous plaque destabilization, followed by healing, and is associated with panvascular inflammation and vulnerability. 8 , 9 Thus, the presence of a layered phenotype may be associated with a vascular response to statin therapy because statins are -Abstract Truncated-

Proteomics associated with coronary high-risk plaques by optical coherence tomography

Clinical determinants of coronary artery disease burden and vulnerability using optical coherence tomography co-registered with intravascular ultrasound

Biomarkers for identification of high-risk coronary artery plaques in patients with suspected coronary artery disease

Outcomes of Non-Ischaemic Coronary Lesions with High-Risk Plaque Characteristics on Coronary CT Angiography

Proteomic Analysis of Serum Proteins from Patients with Severe Coronary Artery Calcification

New Insights into the Association Between Fibrinogen and Coronary Atherosclerotic Plaque Vulnerability: an Intravascular Optical Coherence Tomography Study

Prognostic Implications of Comprehensive Whole Vessel Plaque Quantification Using Coronary Computed Tomography Angiography

Association of Coronary Inflammation with Plaque Vulnerability and Fractional Flow Reserve in Coronary Artery Disease

Serial Optical Coherence Tomography Assessment of Coronary Atherosclerosis and Long-Term Clinical Outcomes

Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients with Coronary Artery Disease.

Predicting the presence of coronary plaques featuring high-risk characteristics using polygenic risk scores and targeted proteomics in patients with suspected coronary artery disease

Plasma Olink Proteomics Reveals Novel Biomarkers for Prediction and Diagnosis in Dilated Cardiomyopathy with Heart Failure

Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes

Coronary Plaque Characterization Assessed by Optical Coherence Tomography and Plasma Trimethylamine-N-oxide Levels in Patients With Coronary Artery Disease.

Association of oxidized ApoB and oxidized ApoA-I with high-risk coronary plaque features in cardiovascular disease

Coronary low-attenuation plaque and high-sensitivity cardiac troponin

Extracellular Matrix Proteomics Identifies Molecular Signature of Symptomatic Carotid Plaques

Higher Noncalcified Plaque Volume Is Associated With Increased Plaque Vulnerability and Vascular Inflammation

Unraveling the proteomic signatures of coronary artery disease and hypercholesterolemia

Optical Coherence Tomography Predictors for a Favorable Vascular Response to Statin Therapy.

Recent advances in proteomic analysis to study carotid artery plaques